-- 週四盤前交易中,標普500指數ETF(SPY)上漲0.1%,活躍交易的景順QQQ ETF(QQQ)上漲0.2%,市場正密切關注即將公佈的經濟數據。 美國股指期貨也小幅走高,標普500指數期貨上漲0.1%,道瓊工業指數期貨上漲0.1%,那斯達克指數期貨在常規交易開始前上漲0.2%。 美國首次申請失業救濟人數為20.7萬人,低於市場預期的21.3萬人和前值21.8萬人。 紐約聯邦儲備銀行4月地區服務業指數為-14.0,低於市場預期的-20.0和前值-22.6。 費城聯邦儲備銀行4月地區製造業指數上升至26.7,高於預期的10.0和前值18.1。 3月份工業生產數據將於美國東部時間上午9:15公佈,隨後是每週天然氣數據,將於美國東部時間上午10:30公佈。 聯準會理事史蒂芬米蘭預計將於週四發表演說。 盤前交易中,比特幣下跌1%。在加密貨幣ETF中,ProShares比特幣策略ETF(BITO)下跌0.8%,以太坊ETF(EETH)下跌2.1%,比特幣和以太坊市值加權ETF(BETH)持平。 強勢板塊: 醫療保健 道富醫療保健精選行業SPDR ETF (XLV) 上漲0.01%,先鋒醫療保健指數基金 (VHT) 上漲0.7%,而iShares美國醫療保健ETF (IYH) 則未成交。 iShares生物技術ETF (IBB) 下跌0.1%。 美國衛生與公眾服務部部長小羅伯特甘迺迪暗示在計劃放寬某些勝肽類藥物的限制後,Hims & Hers Health (HIMS) 股票盤前上漲超過9%。 漲跌板塊: 消費板塊 道富消費必需品精選產業SPDR ETF (XLP) 上漲0.1%,先鋒消費必需品指數基金ETF (VDC) 持平。 iShares美國消費必需品ETF (IYK) 持平。道富非必需消費品精選產業SPDR ETF (XLY) 上漲0.1%。 VanEck零售ETF (RTH) 和道富SPDR標普零售ETF (XRT) 均未成交。 彭博社報道稱,阿里巴巴 (BABA) 推出了一款新的人工智慧模型,可創建3D環境和互動視頻,從而拓展至遊戲和內容領域,與騰訊展開更直接的競爭。受此消息提振,阿里巴巴股價在盤前交易中上漲超過3%。 科技板塊 道富科技精選產業SPDR ETF (XLK) 上漲0.4%,iShares美國科技ETF (IYW) 上漲0.1%,iShares擴展科技業ETF (IGM) 上漲1.2%。半導體ETF方面,道富SPDR標普半導體ETF (XSD) 上漲0.6%,而iShares半導體ETF (SOXX) 下跌0.5%。 儘管台積電 (TSM) 公佈了第一季獲利和淨收入雙雙成長,但其股價在周四盤前交易中仍下跌超過 1%。 能源板塊 iShares 美國能源 ETF (IYE) 下跌 0.02%,而道富能源精選行業 SPDR ETF (XLE) 上漲 0.02%。 道達爾能源 (TTE) 股價在周四開盤前上漲超過 1%,此前該公司表示,受油價上漲和新項目貢獻的支撐,預計第一季勘探和生產業績將大幅增長。 金融板塊 道富金融精選產業 SPDR ETF (XLF) 上漲 0.02%。 Direxion 每日三倍做多金融基金 (FAS) 上漲 0.1%,而其對應的做空基金 Direxion 每日三倍做空金融基金 (FAZ) 上漲 0.02%。 Travelers (TRV) 股價在盤前下跌超過 1%,此前該公司公佈的第一季營收低於 FactSet 調查分析師的預期。 工業板塊 道富工業精選產業 SPDR ETF (XLI) 上漲 0.3%,而先鋒工業指數基金 (VIS) 下跌 0.3%,iShares 美國工業 ETF (IYJ) 則未成交。 Willdan Group (WLDN) 股價在開盤前上漲超過 1%,此前該公司與紐約市長氣候與環境正義辦公室簽訂了一份價值 2700 萬美元、為期三年的合同,負責重新設計和實施紐約市加速器計劃。 大宗商品 紐約商品交易所近月合約美國西德州中質原油上漲 0.2%,至每桶 91.45 美元。天然氣價格下跌0.2%,至每百萬英熱單位2.61美元。美國石油基金(USO)上漲0.8%,美國天然氣基金(UNG)上漲0.5%。 紐約商品交易所(Comex)5月黃金期貨價格上漲0.3%,至每盎司4,840美元。白銀期貨價格上漲0.1%,至每盎司79.68美元。 SPDR黃金信託基金(GLD)上漲0.4%,iShares白銀信託基金(SLV)上漲0.3%。
Related Articles
Oneview Healthcare Reports Decline in Q1 Cash Receipts From Customers; Shares Up 3%
Oneview Healthcare (ASX:ONE) reported cash receipts from customers of about 3.3 million euros for the first quarter, compared with 4.2 million euros a year earlier, according to a Monday filing with the Australian bourse.The company noted that the year-ago figure includes two large customer receipts totaling more than 2 million euros, which were due to be received during the fourth quarter of 2024 but were received in early 2025.Oneview Healthcare ended March with a cash balance of AU$17.1 million, up from AU$8.1 million at the close of 2025, per the filing.The company's shares gained 3% in recent Monday trade.
Paradigm to Advance Participants Through Day 112 Follow-Up Period in Phase Three Knee Osteoarthritis Trial, Shares Reach One-Year Low
Paradigm Biopharmaceuticals (ASX:PAR) is set to progress participants through the day 112 follow-up period for the phase three trial evaluating injectable pentosan polysulfate sodium for the treatment of pain associated with knee osteoarthritis in the June quarter, which is required for inclusion in the interim analysis dataset, according to a Monday Australian bourse filing.The independent statistical analysis results for the data set are expected around August. Timing remains subject to the scheduling and review processes of independent third parties, and there is a reasonable likelihood that final interim outcomes may extend into September, it cautioned.The interim analysis is expected to provide the first phase three evaluation of efficacy and safety for injectable pentosan polysulfate sodium in knee osteoarthritis. Primary endpoint top-line results are expected in the March 2027 quarter.Its shares fell 14% in recent trading on Monday, reaching their lowest point in over a year.
Sanan Optoelectronics Q1 Profit Down 68%, Revenue Slides 33%
Sanan Optoelectronics (SHA:600703) posted first-quarter attributable net profit of 67.5 million yuan, down 68% from 211.9 million yuan the previous year.Earnings per share declined to 0.01 yuan from 0.04 yuan, according to a weekend filing with the Shanghai bourse.Operating revenue declined 33% year over year to 2.91 billion yuan from 4.31 billion yuan.Shares of the software company declined 2% in recent trade.